Branding of Condoms

UNFPA
Branding of Condoms Request for quotation

Reference: UNFPA/MOZ/RFQ/22/021
Beneficiary countries or territories: Mozambique
Registration level: Basic
Published on: 28-Oct-2022
Deadline on: 08-Nov-2022 17:00 (GMT 2.00)

Description

The condom made available and distributed free of charge by the Government, commonly called “the white condom”, was introduced in the early 1990s in the context of the fight against HIV and AIDS. This condom has as its target group, sexually active men and women and the population in general, with a particular focus on adolescents and young people between 15 and 24 years old.

The “white condom” is often rejected by the consumer, influenced by factors such as it having no brand/name, and a rubbery smell, amongst others. About 5 years ago, the “white condom” was placed in the distribution chain with a flavoured additive (chocolate, strawberry, banana, vanilla), and although there was an increase in the demand, it was not substantial to achieve the desired result.

In this context, the National Council for the Fight against AIDS (CNCS), with the support of the United Nations Population Fund (UNFPA) and the Joint United Nations Program on HIV and AIDS (UNAIDS), carried out provincial consultations in 2021 among youth organizations to define the name for the “white condom” (proposed names included Cool, Biz, Maningue Biz, Nova Vibe and Boa cena). The proposed name with the greatest acceptance was “Boa Cena”. Within this context, UNFPA and UNAIDS, in coordination with CNCS, intend to hire a company specialized in communication and marketing to create a brand for the “white condom” and include the name “Boa Cena” amongst the names to be considered. The company will carry out the testing of the created brand, as well as elaborate an advertising campaign including the design of the logo, slogan and branded condom package.

General Purpose

Increase the visibility and acceptance of condoms in the market, especially amongst adolescents and young people, as a product that offers “Double Protection”: reducing the risk of Sexually Transmitted Infections (STIs), including HIV, and unintended pregnancies.